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Central venous catheters represent a major source of nosocomial bloodstream infections,
which cause considerable excess morbidity. It is currently unknown to what extent these
infections contribute to mortality. Most catheter-related infections (CRIs) are caused by
Gram-positive organisms (mainly coagulase-negative staphylococci). Definite diagnosis
of CRI necessitates removal of the catheter in most cases. However, the recently described
technique of differential time to positivity may allow diagnosis of CRI with the catheter
left in place. Removal of the catheter has been standard clinical practice for the manage-
ment of CRI in the past and is still recommended in many cases. In specific situations,
such as infections of implanted catheters with coagulase-negative staphylococci, a trial of
catheter salvage may be justified. In catheter-related bloodstream infection Staphylococcus
aureus and Candida spp., the catheter should be removed immediately, due to the high
risk of metastatic infection and increased mortality. A clinical work-up for the detection
of additional foci (including transesophageal echocardiography in S. aureus infections) is
advisable in these cases. All CRIs should be treated with antibiotics to which the causative
agent has been shown to be susceptible. In addition to systemic antimicrobial therapy,
antibiotic lock therapy may be applied, especially in patients with implanted long-term
catheters if catheter salvage is attempted.
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B A C K G R O U N D
Central venous catheters represent a leading
source of nosocomial infection. In clinical studies,
11–37% [1–3] of nosocomial bacteremias have been
related to central lines. The incidence rate of cathe-
ter-related infections (CRIs) is about 5 million per
1000 catheter days in the USA. An estimated 75 000
infections per year will result in additional expen-
diture of $300 million to $2.3 billion [4].
Many new papers on the pathogenesis, preven-
tion and diagnosis of CRIs have been published
during recent years. In this review, we will mainly
focus on the clinical management of these infec-
tions.
D E F I N I T I O N S
Clear definition should be used, when describing
the clinical diagnosis of CRI. The term ‘catheter
infection’ should be avoided, since it does not
clearly distinguish between colonization (of the
catheter) and infection (of the host). Catheter-
related bloodstream infection (CRBSI) is the most
important clinical manifestation. Diagnosis of
CRBSI requires the demonstration of the same
pathogen on the catheter surface and in blood
cultures [5]. Another clinical form of CRI is exit-
site infection, which is defined as skin inflamma-
tion at the site of the catheter insertion and which
may or may not be accompanied by CRBSI. Tunnel
infection is characterized as a soft tissue infection
along the tunnel of an implanted catheter at least
2 cm from the exit site [6]. Accordingly, pocket
infections are defined as subcutaneous infections
around a port reservoir. Septic thrombophlebitis
is characterized by bacteremia and purulent
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phlebitis, and is one of the most serious complica-
tions of CRI [7].
A T T R I B U T A B L E M O R B I D I T Y
A N D M O R T A L I T Y
While there is broad consensus that CRIs cause
excess morbidity, data on attributable mortality
are not consistent. In their sentinel study, Pittet et
al. found an attributable mortality of 35% in criti-
cally ill surgical patients with bloodstream infec-
tions [8]. The attributable mortality of CRI has been
estimated at 25% [9,10]. In contrast, a recently
published case–control study did not find any
excess mortality for CRI, although these infections
caused prolonged hospitalization for an average of
20 days. Hospital costs were estimated to be
increased by 3000 Euro per case in this study
[11]. The favorable outcome of patients with CRI
in this study may be explained by the predomi-
nance of infections caused by coagulase-negative
staphylococci (63%). It has been shown in many
other studies that mortality from infections with
these organisms is considerably lower than from
infections caused by Staphylococcus aureus or Gram-
negative rods. These observations have been con-
firmed by another study which showed that
outcome in nosocomial bacteremia is better when
it is caused by intravenous catheters as compared
to other sources, such as pneumonia or abdominal
infections [2].
R I S K F A C T O R S
Several host factors that predispose for CRI have
been identified. Malignant hematologic disorders
and AIDS increase the risk of CRI about four times,
but the most important risk factor is neutropenia,
with an 11-fold increased risk [12]. Other risk
factors include the type of catheter and the site
of insertion. In general, infection rates are sub-
stantially lower in patients with tunneled cathe-
ters than in patients with non-tunneled catheters
[5,13].
It has been shown by several studies that a
reduction of infection rates can be achieved with
impregnated catheters [14–16]. The best results
have been observed with the use of a catheter
impregnated with minocycline and rifampicin
on both the luminal and external surfaces. Com-
pared to a catheter impregnated with silver sulfa-
diazine and chlorhexidine on the external surface,
this type of catheter reduced the risk of CRBSI
significantly [16].
In the past, multilumen catheters have been
associated with an increased risk of infection
[17–19]. However, a recently published rando-
mized study did not find a difference between
single- and multi-lumen catheters [20].
Among the possible insertion sites for central
venous catheters, the subclavian vein is associated
with the lowest risk of infection [5].
E T I O L O G Y
Most CRIs are caused by Gram-positive organ-
isms. Coagulase-negative staphylococci are most
frequently cultured, followed by S. aureus, Gram-
negative bacilli and Candida species [13,21]. Isola-
tion of the causative agent is crucial, as clinical
management of infections varies according to the
organism. Another argument for a rigorous search
for the pathogen is resistance. Many of the organ-
isms causing CRIs are resistant to commonly used
antimicrobials. Frequent patterns in CRIs include
methicillin resistance of coagulase-negative sta-
phylococci and S. aureus, vancomycin resistance
of enterococci, b-lactam resistance of Gram-nega-
tive bacilli, and fluconazole resistance of Candida
species.
D I A G N O S I S
The role plate technique of Maki et al. [22] is the
most frequently used method to diagnose CRI. A
diagnosis of CRBSI is established when the cathe-
ter yields more than 15 colony-forming units per
segment and the blood culture is positive for the
same organism. With another technique, using
sonication and flushing of the lumen, diagnostic
sensitivity may be increased [23]. Both techniques
require the removal of the catheter. With quanti-
tative blood cultures drawn from the catheter and
from peripheral venipuncture, it is possible to
diagnose CRI with the catheter left in place [24].
However, the technique requires specific blood
culture systems and sophisticated logistics and
has therefore not been widely used in clinical
practice.
Recently, a very elegant method has been
described using the differential time to positivity
(DTP) of blood cultures drawn simultaneously
from peripheral veins and central lines [25]. Using
a cut-off of 2 h for DTP, Blot et al. showed that this
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method has excellent sensitivity and specificity, as
well as positive and negative predictive values
[26]. Further studies are needed to evaluate the
utility of this method under different clinical con-
ditions.
C A T H E T E R R E M O V A L
The question of whether the catheter has to be
removed is dependent on different factors con-
cerning the patient, the pathogen, and the catheter
itself. It is advisable to remove the catheter in any
patient with severe sepsis or septic shock. When
the patient is in a stable condition, the catheter may
be left in place under certain circumstances. Raad
et al. have shown in a retrospective review that
infections caused by coagulase-negative staphylo-
cocci may be successfully managed with the cathe-
ter in situ in 50% of patients. However, recurrent
bacteremia occurred in 20%, as compared to 3% of
patients with immediate catheter removal [27].
Other studies have shown more favorable results.
In pediatric patients, catheter salvage was success-
ful in five of six (83%) infections with coagulase-
negative staphylococci [28]. Very similar results
have been reported by other investigators, show-
ing a cure rate of 88% without catheter removal in
children with malignant diseases and port infec-
tions caused by coagulase-negative staphylococci
[29]. Given the relatively low pathogenicity of
coagulase-negative staphylococci [2], an attempt
at catheter salvage is justified in these infections,
especially in the case of implanted long-term
catheters. This approach is supported by a guide-
line that has been established recently by the
Infectious Diseases Society of America (IDSA)
[4]. Any attempt at catheter salvage has to be
accompanied by appropriate antibiotic therapy.
In the case of S. aureus infection, rapid catheter
removal is recommended by most experts. Many
studies with different catheter types have shown
that catheter salvage is successful in only a min-
ority of patients. In patients with hemodialysis
catheters and S. aureus infections, 12 of 62 episodes
(19%) could be managed without catheter removal
[30]. Similar results have been reported in patients
with Hickman catheters [31]. In contrast to these
figures, a much higher success rate (68%) has been
described in a pediatric population with implant-
ed port catheters [29].
The risk of deep-seated metastatic infections,
such as endocarditis, osteomyelitis and septic
thrombosis is a major argument for rapid catheter
removal in cases of CRBSI due to S. aureus. Com-
plicated S. aureus infections resulting from bacter-
emia have been described with rates of 16% and
more [32,33]. It has also been reported that
increased mortality in S. aureus bacteremia may
be related to non-removal of the catheter [34].
Taking these results together, rapid catheter
removal is advisable as standard procedure in S.
aureus CRBSI, and catheter salvage may be limited
to special situations [4].
Little evidence is available in the current litera-
ture to serve as a guideline for catheter manage-
ment in Gram-negative infections [35]. In a
retrospective review which investigated infections
due to Stenotrophomonas maltophilia and Pseudomo-
nas species, catheter removal was found to be
associated with lower mortality [36]. Likewise,
in bacteremia due to Acinetobacter baumannii,
catheter removal has been shown to reduce mor-
tality [37]. Therefore, most experts currently
recommend rapid catheter removal in cases of
Gram-negative infections.
When the infection is caused by Candida species,
attempts at catheter salvage are not indicated. In a
retrospective review of candidemia at the National
Cancer Institute, nine of 11 patients with the cathe-
ter left in place had an unfavorable outcome [38].
These results are supported by a large prospective
study performed by Nguyen et al., demonstrating
that a significant increase in mortality is associated
with non-removal [39]. Thus, in the presence of
candidemia, intravenous catheters should be
removed immediately.
Rarely, CRIs are caused by mycobacteria. These
infections can only be managed successfully with
catheter removal [40].
Irrespective of the pathogen, tunnelled catheters
or ports should be removed in the presence of
tunnel or pocket infection [41]. Likewise, in the
case of septic thrombosis, attempts at catheter
salvage are not recommended as they will even-
tually result in metastatic infection.
A N T I M I C R O B I A L T H E R A P Y
Although removal of the catheter alone may result
in clinical cure in selected cases, it is generally
recommended to treat CRBSI systemically with
appropriate antibiotics. Choice and duration of
antimicrobial therapy depend on the isolated
pathogen, the resistance pattern, and the presence
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of complications, such as deep-seated infections.
Vancomycin is often given in cases of suspected
or established CRI. However, its use should be
reserved for infections with pathogens that are not
susceptible to b-lactams. Since no randomized
trials have been performed to examine optimal
treatment modalities for CRIs, recommendations
are based mainly on observational studies and
expert opinion.
Most coagulase-negative staphylococci are
resistant to b-lactam antibiotics and require treat-
ment with glycopeptides. The optimal duration of
treatment is not established, but most experts
recommend antibiotic treatment for 7–10 days.
Staphylococcus aureus infections should be trea-
ted with appropriate antibiotics (preferably b-lac-
tams) given intravenously for at least 2 weeks.
However, in cases of complicated infections, such
as endocarditis, osteomyelitis or septic thrombo-
sis, or in patients with prolonged fever under
appropriate antimicrobial therapy, much longer
periods are needed (4–6 weeks for endocarditis,
and 6–8 weeks for osteomyelitis) [4].
Recently, new antimicrobial agents targeting
Gram-positive infections (quinoprustin/dalfopris-
tin and linezolid) have been introduced into clin-
ical practice. Their specific value in CRI has not yet
been established and they should be retained for
infections with organisms resistant to vancomycin
or for patients with intolerance to other susceptible
antibiotics.
Gram-negative infections may include a wide
range of pathogens and have to be treated accord-
ing to culture results and antimicrobial suscept-
ibility testing. There are no data available on
the optimal duration of therapy, but treatment
periods of 7–10 days might be sufficient in most
cases.
Intravenous fluconazole is the drug of choice for
CRBSI due to Candida spp. [42]. In the rare cases
caused by organisms not susceptible to flucona-
zole (such as C. krusei), treatment has to be chan-
ged to amphotericin B as soon as species
differentiation is available.
In the near future, new azole antifungals with
extended spectra will probably be available. How-
ever, their application in CRI has not yet been
studied. Caspofungin, another newly developed
antifungal agent of the echinocandin class, has
shown substantial efficacy against a wide range
of Candida species and will also extend our ther-
apeutic armamentarium for fungal infections.
A N T I B I O T I C L O C K T H E R A P Y
The instillation of antibiotics in high concentra-
tions into the catheter over a period of 12–24 h has
been demonstrated to be effective in eliminating
catheter-related bacteremia in several studies [43–
45]. Different substances have been used accord-
ing to the susceptibility of the underlying organ-
ism (e.g. vancomycin, ciprofloxacin, gentamicin).
Although controlled trials comparing different
approaches have not been performed, the method
has been recommended by an expert committee of
the Infectious Diseases Society of America for the
treatment of uncomplicated infections in patients
with implanted long-term catheters [4].
A D D I T I O N A L P R O C E D U R E S
In all cases of CRBSI, control blood cultures should
be obtained until eradication of the pathogen from
the bloodstream has been demonstrated. If a CRI is
suspected, any removed catheter should be exam-
ined microbiologically to establish the diagnosis.
Especially in cases of central catheter-related
bloodstream infections due to S. aureus and Can-
dida spp., it is clinically important to rule out
metastatic infections. Endocarditis is the most
devastating consequence of staphylococcal infec-
tion. Therefore, the role of echocardiography is an
important consideration in the clinical manage-
ment of these infections. In recently published
studies, it was shown that transesophageal echo-
cardiography (TEE) is a very sensitive and cost-
effective method with which to diagnose endocar-
ditis associated with S. aureus infection [46,47].
These results have led to the recommendation that
TEE should be performed in each patient with S.
aureus bloodstream infection unless contraindica-
tions are present [4].
The value of other diagnostic procedures aimed
at detecting metastatic infections has been inves-
tigated less systematically. From a clinical point of
view, it seems advisable to perform scintigraphy
and X-ray examinations in the case of patients all
with clinical symptoms of bone infection.
In patients with prolonged fever or persisting
bacteremia despite adequate antibiotic therapy,
the aforementioned examinations are mandatory.
In addition, abdominal sonography and computer
tomography of the chest and abdomen should be
performedto searchfor infectious foci. Patientswith
Candida bloodstream infections should undergo
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ophthalmoscopic examination to rule out endo-
phthalmitis.
C O N C L U S I O N
An accurate diagnosis, adequate antimicrobial
therapy and a rational decision concerning cathe-
ter removal are the main steps in the clinical
management of CRI. In the past, a definite diag-
nosis of CRBSI could be established only after
catheter removal in virtually all cases. The newly
developed technique of DTP will eventually allow
an exact diagnosis with the catheter left in place
and may help the clinician in guiding therapy.
Intravenous therapy should be applied for a suffi-
cient period of time, especially for infections due to
S. aureus and Candida spp. Removal of the catheter
will be necessary in the majority of cases. How-
ever, in selected cases, such as uncomplicated
infections due to coagulase-negative staphylo-
cocci, catheter salvage may be attempted.
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